[Use of monotreane in the treatment of patients with cochleovestibular disorders].
Patients with cochleovestibular disorders of central and peripheral origin were treated with monothreane (produced by Luitpold Werk, FRG). The drug was given to 70 patients (19 men and 51 women) at the age of 28 to 64 years, 28 patients of which had disorders of peripheral origin and 42 patients disorders of mixed origin. The patients were examined by clinical methods and special tests and hypertension was diagnosed in 32 patients. The therapy yielded good effects in 61 patients: complete recovery of vestibular disorders was seen in 28 patients and relief of headaches in 42 subjects. Side effects were observed in nine patients who showed reduction of perception thresholds which disappeared after drug withdrawal. Monothreane had a beneficial effect on the course of the hypertensive disease.
Pal'chun
V T
VT
Kadymova
M I
MI
Kriukov
A I
AI
D000328:Adult; D001299:Audiometry; D015834:Cochlear Diseases / Q000175:diagnosis / Q000188:drug therapy*; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008575:Meniere Disease / Q000175:diagnosis / Q000188:drug therapy; D008875:Middle Aged; D010208:Papaverine / Q000009:adverse effects / Q000627:therapeutic use*; D010992:Plethysmography, Impedance; D011803:Quinine / Q000009:adverse effects / Q000627:therapeutic use*; D015837:Vestibular Diseases / Q000175:diagnosis / Q000188:drug therapy*
D004338:Drug Combinations; C061791:monothreane; D011803:Quinine; D010208:Papaverine
Primenenie monotreana pri lechenii bol'nykh s kokhleovestibuliarnymi narusheniiami.